Lithium Attenuates Scopolamine-Induced Memory Deficits with Inhibition of GSK-3β and Preservation of Postsynaptic Components-Reference-Cited by-同舟云学术

Lithium Attenuates Scopolamine-Induced Memory Deficits with Inhibition of GSK-3β and Preservation of Postsynaptic Components

Published:2013-09-24 Issue:3 Volume:37 Page:515-527
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Wu Yuan-Yuan¹,Wang Xiong¹,Tan Lu¹,Liu Dan²³,Liu Xing-Hua¹,Wang Qun¹³,Wang Jian-Zhi¹³,Zhu Ling-Qiang¹³

Affiliation:

1. Department of Pathophysiology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China

2. Department of Genetics, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China

3. Key Laboratory of Neurological Diseases of Education Ministry of China, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GSK3: A potential target and pending issues for treatment of Alzheimer's disease;CNS Neuroscience & Therapeutics;2024-07

2. Polypeptide-PNP2 in Corn Cervi Pantotrichum Ameliorates Cognitive Impairment in Alzheimer’s Disease Mice by Inhibiting Microglial Cell Activation;Molecular Neurobiology;2024-06-17

3. Function of GSK‑3 signaling in spinal cord injury (Review);Experimental and Therapeutic Medicine;2023-10-03

4. Lithium: An Old Drug for New Therapeutic Strategy for Alzheimer’s Disease and Related Dementia;Neurodegenerative Diseases;2023

5. Systems pharmacology approach uncovers the therapeutic mechanism of medicarpin against scopolamine-induced memory loss;Phytomedicine;2021-10